Inhibikase Therapeutics, Inc. (IKT) has 9 open-market insider trades by 6 insiders since 2021. The most active filer is Milton H. Werner, President & 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Frank M. Sands | 10% Owner | — | 1 | $6.0M | 2025-11-21 |
| Roberto Bellini | Dir | — | 1 | $4.0M | 2024-10-21 |
| Amit Munshi | Dir | — | 1 | $1.0M | 2026-02-21 |
| Arvind Kush | Dir | — | 1 | $397K | 2024-10-21 |
| Milton H. Werner | Pres10% | — | 4 | $61K | 2022-08-16 |
| Joseph Frattaroli | CFO | — | 1 | $3K | 2022-05-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Frank M. Sands | 10% Owner | Buy | $6.0M | 2025-11-21 |
| Roberto Bellini | Director | Buy | $4.0M | 2024-10-21 |
| Arvind Kush | Director | Buy | $397K | 2024-10-21 |
| Amit Munshi | Director | Buy | $1.0M | 2024-10-21 |
| Milton H. Werner | President & 10% | Buy | $4K | 2022-08-16 |
| Milton H. Werner | President & 10% | Buy | $5K | 2022-05-27 |
Companies that share insiders with IKT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Milton H. Werner | President & 10% | Buy | $6K | 2022-05-20 |
| Joseph Frattaroli | CFO | Buy | $3K | 2022-05-19 |
| Milton H. Werner | President & 10% | Buy | $47K | 2021-11-17 |